ID: ALA2013185

Max Phase: Preclinical

Molecular Formula: C15H16ClN7O3

Molecular Weight: 377.79

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC(N)=NC(=O)c1nc(Cl)c(NCC(=O)OCc2ccccc2)nc1N

Standard InChI:  InChI=1S/C15H16ClN7O3/c16-11-13(22-12(17)10(21-11)14(25)23-15(18)19)20-6-9(24)26-7-8-4-2-1-3-5-8/h1-5H,6-7H2,(H3,17,20,22)(H4,18,19,23,25)

Standard InChI Key:  ZPLJNBMTYKRIDX-UHFFFAOYSA-N

Associated Targets(Human)

Urokinase-type plasminogen activator 2016 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tissue-type plasminogen activator 1057 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasminogen 2339 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 377.79Molecular Weight (Monoisotopic): 377.1003AlogP: 0.28#Rotatable Bonds: 6
Polar Surface Area: 171.60Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 7#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.03CX LogP: 0.76CX LogD: 0.61
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.31Np Likeness Score: -0.82

References

1. Massey AP, Harley WR, Pasupuleti N, Gorin FA, Nantz MH..  (2012)  2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator.,  22  (7): [PMID:22366654] [10.1016/j.bmcl.2011.12.123]

Source